Prestige Consumer Healthcare Inc.
NYSE:PBH · New York Stock Exchange
+$0.23 today
Vol 1.27M · Avg 0.67M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NYSE:PBH · Revenue to Net Income
Key Ratios
Analysis
$1.1B of revenue converted into $190.3M of net income for the selected period. Gross margin is 54.0% and net margin is 17.5%, showing how much revenue survives after costs and taxes. EPS is $3.91, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B -4.3% | $1.1B +1.1% | $1.1B -0.2% | $1.1B +3.8% | $1.1B | $1.0B | $809.6M | $921.6M |
| Cost of Revenue | $514.1M +2.1% | $503.3M +0.5% | $500.9M -0.3% | $502.4M +7.8% | $466.2M | $344.8M | $725.6M | $804.0M |
| Gross Profit | $574.6M -9.4% | $634.5M +1.6% | $624.4M -0.1% | $625.3M +0.7% | $620.6M | $10.3B | $8.9B | $7.6B |
| Gross Margin | 52.8% -3.0pp | 55.8% +0.3pp | 55.5% +0.0pp | 55.4% -1.7pp | 57.1% | 45.5% | 9.8% | 28.9% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $378.4M | $983.2M | $1.3B |
| Selling, General & Admin | $265.2M +0.5% | $263.9M +1.7% | $259.5M +2.8% | $252.4M -4.7% | $264.8M | $1.4B | $620.6M | $923.0M |
| Operating Expenses | $265.2M -10.9% | $297.7M +5.6% | $282.0M -56.5% | $647.7M +122.8% | $290.7M | $3.6B | $5.3B | $7.0B |
| Depreciation & Amortization | $31.3M +3.6% | $30.2M -1.6% | $30.7M -6.0% | $32.6M +1.7% | $32.1M | $1.2B | $374.2M | $1.2B |
| EBITDA | $331.1M -8.5% | $362.0M -3.2% | $373.9M +4648.0% | $7.9M -97.8% | $358.8M | $12.6B | -$15.2B | $6.8B |
| EBITDA Margin | 30.4% -1.4pp | 31.8% -1.4pp | 33.2% +32.5pp | 0.7% -32.3pp | 33.0% | 10.0% | 5.6% | 46.3% |
| Operating Income | $309.4M -8.1% | $336.8M -1.7% | $342.4M +1627.7% | -$22.4M -106.8% | $329.9M | $10.6B | $12.3B | $14.0B |
| Operating Margin | 28.4% -1.2pp | 29.6% -0.8pp | 30.4% +32.4pp | -2.0% -32.3pp | 30.4% | 18.7% | 16.6% | 24.1% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $1.3B | -$1.5B | -$1.6B |
| Interest Expense | $42.3M -11.1% | $47.6M -29.1% | $67.2M -2.9% | $69.2M +7.6% | $64.3M | $969.2M | $1.1B | $1.0B |
| Other Income / Expenses | -$51.9M +1.3% | -$52.6M +20.8% | -$66.4M +7.1% | -$71.5M -6.0% | -$67.5M | -$1.6B | -$1.5B | $1.4B |
| Income Before Tax | $257.5M -9.4% | $284.2M +3.0% | $276.0M +393.9% | -$93.9M -135.8% | $262.5M | -$15.6B | $3.3B | $4.9B |
| Pre-Tax Margin | 23.7% -1.3pp | 25.0% +0.5pp | 24.5% +32.9pp | -8.3% -32.5pp | 24.1% | 13.3% | 20.8% | 18.7% |
| Income Tax Expense | $67.2M -3.4% | $69.6M +4.3% | $66.7M +674.4% | -$11.6M -120.3% | $57.1M | $666.8M | $1.3B | -$1.6B |
| Net Income | $190.3M -11.3% | $214.6M +2.5% | $209.3M +354.3% | -$82.3M -140.1% | $205.4M | $5.0B | $4.9B | $4.8B |
| Net Margin | 17.5% -1.4pp | 18.9% +0.3pp | 18.6% +25.9pp | -7.3% -26.2pp | 18.9% | 7.4% | 12.4% | 17.5% |
| EPS (Basic) | $4 -9.0% | $4 +2.6% | $4 +355.2% | -$2 -140.3% | $4 | $1.2B | $400.8M | $703.2M |
| EPS (Diluted) | $4 -8.9% | $4 +2.9% | $4 +352.7% | -$2 -140.8% | $4 | $620.6M | $766.2M | $609.4M |
| Weighted Avg Shares | $48.5M -2.5% | $49.7M -0.1% | $49.8M -0.3% | $49.9M -0.7% | $50.3M | $892.2M | $757.8M | $925.8M |
| Weighted Avg Shares (Diluted) | $48.7M -2.7% | $50.1M -0.2% | $50.2M +0.6% | $49.9M -1.9% | $50.8M | $319.6M | $1.2B | $924.4M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Legend Biotech Corporation
NASDAQ:LEGN
$5.33B
LivaNova PLC
NASDAQ:LIVN
$4.34B
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.65B
ICU Medical, Inc.
NASDAQ:ICUI
$3.49B
Privia Health Group, Inc.
NASDAQ:PRVA
$2.97B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.88B
Disc Medicine, Inc.
NASDAQ:IRON
$2.68B
Zai Lab Limited
NASDAQ:ZLAB
$2.08B
Alphatec Holdings, Inc.
NASDAQ:ATEC
$1.33B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does PBH generate?
Prestige Consumer Healthcare Inc. (PBH) reported $1.09B of revenue in fiscal 2026.
Is PBH profitable?
Prestige Consumer Healthcare Inc. (PBH) reported $190.30M of net income, with a net margin of 17.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.